C. Debruyne
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 19
- Lung Cancer Diagnosis and Treatment 10
- Occupational and environmental lung diseases 9
- Pleural and Pulmonary Diseases 5
- Genetics top 1%
- Oncology top 2%
- Lung Cancer Research Studies 20
- Cancer Immunotherapy and Biomarkers 7
- Otorhinolaryngology top 5%
-
- Neuroendocrine Tumor Research Advances 7
-
- Neuroblastoma Research and Treatments 5
- Co-authors
- Giuseppe GiacconeJan P. van MeerbeeckEgbert F. SmitBonne BiesmaRabab GaafarDesmond CurranFranz M.N.H. SchramelNico van Zandwijk
- Journals
- Journal of Clinical Oncology (15 papers)European Journal of Cancer (8 papers)Annals of Oncology (5 papers)
- Partner nations
- NetherlandsBelgiumItaly
In The Last Decade
C. Debruyne
47 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Pulmonary and Respiratory Medicine 2.4k
- Genetics 679
- Oncology 1.6k
- Otorhinolaryngology 109
- Radiology, Nuclear Medicine and Imaging 437
Countries citing papers authored by C. Debruyne
This map shows the geographic impact of C. Debruyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Debruyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Debruyne more than expected).
Fields of papers citing papers by C. Debruyne
This network shows the impact of papers produced by C. Debruyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Debruyne. The network helps show where C. Debruyne may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Debruyne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 13 | |
| 2 | 2019 | 11 | |
| 3 | MAGE-A3 GENE EXPRESSION FREQUENCY AND DEMOGRAPHY DATA OF STAGE IB-IIIA NSCLC PATIENTS FROM ONGOING MAGRIT PHASE III TRIAL EVALUATING MAGE-A3 ANTIGEN SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT TREATMENT | 2010 | 6 |
| 4 | MAGRIT phase III trial in adjuvant NSCLC: MAGE-A3 gene expression frequency on the first 2150 patients screened and demographics of first patients randomized | 2009 | 2 |
| 5 | 2009 | 24 | |
| 6 | Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancerbreakdown → | 2007 | 471 |
| 7 | 2006 | 150 | |
| 8 | 2003 | 46 | |
| 9 | 2003 | 46 | |
| 10 | 2003 | 82 | |
| 11 | 2003 | 19 | |
| 12 | 2002 | 192 | |
| 13 | 2002 | 75 | |
| 14 | 2002 | 5 | |
| 15 | 2001 | 79 | |
| 16 | 1999 | 109 | |
| 17 | 1997 | 3 | |
| 18 | 1996 | 67 | |
| 19 | 1991 | 9 | |
| 20 | 1990 | 27 |
About C. Debruyne
C. Debruyne is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 49 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (20 papers), Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Diagnosis and Treatment (10 papers), Occupational and environmental lung diseases (9 papers), Neuroendocrine Tumor Research Advances (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Pleural and Pulmonary Diseases (5 papers) and Neuroblastoma Research and Treatments (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.4k citations), Genetics (679 citations) and Oncology (1.6k citations). C. Debruyne has collaborated with scholars based in Netherlands, Belgium and Italy. Frequent co-authors include Giuseppe Giaccone, Jan P. van Meerbeeck, Egbert F. Smit, Bonne Biesma, Rabab Gaafar, Desmond Curran, Franz M.N.H. Schramel, Nico van Zandwijk, Catherine Legrand and Eric A. Van Marck. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Lung Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.